The pharmacological inhibition of the PI3K/AKT/mTORC1 and MEK/ERK pathways underlined the contribution of both mechanisms to eIF4E phosphorylation in cervical cancer cell lines (Fig. 4). The gene discussed is MAPK1; the disease is cervical carcinoma.